PharmEng (PII.V) Obtained Court Approval for the Sale of the Consulting Business Assets
7/29/2009 11:32:48 AM
More...
|
PharmEng (PII.V): Sales Process Initiated for the Assets of PharmEng International Inc., Keata Pharma Inc. and PharmEng Technology Inc.
5/15/2009 2:08:06 PM
More...
|
PharmEng (PII.V) Unable to File Its 2008 Audited Annual Financial Statements and Closes Sydney Manufacturing Facility
4/23/2009 8:23:15 AM
More...
|
PharmEng (PII.V) has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009 10:41:21 AM
More...
|
PharmEng (PII.V) has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009 10:39:49 AM
More...
|
PharmEng (PII.V) Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada)
4/15/2009 10:46:55 AM
More...
|
PharmEng (PII.V) Announces Resignation of Director
4/14/2009 10:46:53 AM
More...
|
PharmEng (PII.V) Announces Corporate Changes; CEO Takes 50% Salary Reduction
4/13/2009 7:12:30 AM
More...
|
PharmEng (PII.V) to Receive Government Financial Support for Research Into Treatment for Alzheimer's Disease
2/2/2009 12:39:05 PM
More...
|
PharmEng (PII.V) Announces New Supply Agreement With Multi-National Consumer Healthcare Company
1/6/2009 11:26:31 AM
More...
|
|